Clinical trials recruiting for Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Empagliflozin (oral) | 1 |
| autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Illinois | 1 |
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
- Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Related conditions
Trials recruiting for Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.